15 May 2024
Second generation biolimus drug-coated balloon in clinical practice
Sponsored by Biosensors International
Anchorperson:
H. C. Tan
Spokesperson:
C. T. Chin
Summary
Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel, bifurcation, and side-branch lesions in real-world scenarios through this session.
Learning Objectives
- To understand the role of limus drug-coated balloon in modern interventional cardiology
- To receive the latest clinical evidence of limus versus paclitaxel coated balloons from the BIO ASCEND ISR study
- To learn about practical experiences on the use of limus drug-coated balloon in small vessels and de novo coronary lesions
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)